1-3
2026
影响因子区间
—
平台估算
2%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of breast cancer. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as prevention, systemic therapy, and translational research. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.
【译文】本期刊旨在回顾与乳腺癌诊断、治疗、管理和预防相关的最新临床发现。通过提供国际专家清晰、深刻、平衡的贡献,该期刊旨在服务于所有参与疾病护理的人员。我们通过任命国际权威人士担任关键领域的部门编辑,如预防、系统治疗和转化研究,来实现这一目标。部门编辑随后选择主题,由领先的专家撰写全面综述文章,强调新发展和最近发表的具有重大意义的研究论文,并附有注释参考文献列表。国际编委会审查年度目录,建议对其国家/地区有特殊兴趣的文章,并确保主题是当前的和包括新兴研究。该领域知名人士的评论也一并提供。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q4 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |